MedPlus Health Services Limited (NSE:MEDPLUS)
India · Delayed Price · Currency is INR 598.00
-11.40 (-1.87%)
Oct 29, 2026, 3:30 PM IST
MedPlus Health Services Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 75,951 | 68,925 | 61,361 | 56,249 | 45,576 | 37,793 |
Revenue Growth | 20.69% | 12.33% | 9.09% | 23.42% | 20.59% | 23.13% |
Gross Profit Gross Profit Growth | 19,160 | 17,789 | 14,705 | 12,143 | 9,818 | 7,855 |
Operating Income Operating Income Growth | 3,459 | 3,418 | 2,502 | 1,423 | 960.92 | 1,627 |
Net Income Net Income Growth | 2,110 | 2,196 | 1,502 | 654.73 | 497.63 | 958.02 |
Earnings Per Share EPS Growth | 17.63 | 18.29 | 12.52 | 5.45 | 4.17 | 8.52 |
EPS Growth | 8.46% | 46.09% | 129.72% | 30.70% | -51.06% | 44.65% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Retail Retail Growth | 67,601 | 60,269 | 55,491 | 45,269 | 37,479 |
Diagnostic Services Diagnostic Services Growth | 1,310 | 1,081 | 748.85 | 305.54 | 74.76 |
Others Others Growth | 13.73 | 10.6 | 9.18 | 1.52 | - |
Total Total Growth | 68,925 | 61,361 | 56,249 | 45,576 | 37,554 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 5,574 | 5,925 | 4,399 | 1,650 | 2,284 | 214.88 |
Total Debt Total Debt Growth | 15,490 | 14,244 | 11,198 | 10,096 | 8,999 | 8,149 |
Net Cash (Debt) Net Cash Growth | -9,916 | -8,319 | -6,800 | -8,445 | -6,715 | -7,934 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -82.82 | -69.27 | -56.65 | -70.36 | -56.12 | -70.54 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 3,425 | 4,956 | 5,404 | 1,437 | 904.08 | 1,699 |
Capital Expenditures CapEx Growth | -1,578 | -1,230 | -594.5 | -843.99 | -1,690 | -1,177 |
Free Cash Flow Free Cash Flow Growth | 1,847 | 3,726 | 4,810 | 593.38 | -785.97 | 521.68 |
Free Cash Flow Growth | -63.63% | -22.54% | 710.57% | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 25.23% | 25.81% | 23.96% | 21.59% | 21.54% | 20.78% |
Operating Margin | 4.55% | 4.96% | 4.08% | 2.53% | 2.11% | 4.30% |
Pretax Margin | 3.50% | 3.99% | 2.99% | 1.31% | 1.03% | 3.12% |
Profit Margin | 2.78% | 3.19% | 2.45% | 1.16% | 1.09% | 2.54% |
FCF Margin | 2.43% | 5.41% | 7.84% | 1.05% | -1.73% | 1.38% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 33.92 | 45.92 | 60.55 | 125.58 | 155.76 | 126.34 |
Forward PE | 33.34 | 42.61 | 48.95 | 83.56 | 101.15 | 82.82 |
P/FCF Ratio | 38.89 | 27.07 | 18.91 | 138.57 | - | 232.01 |
PS Ratio | 0.95 | 1.46 | 1.48 | 1.46 | 1.70 | 3.20 |